Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 201–300 of 998
Pervizaj-Oruqaj, L., Ferrero, M. R., Matt, U., & Herold, S. (2024) · European Respiratory Review · doi:10.1183/16000617.0263-2023 · Cited by 82
“C chemokine receptor (CCR) 2-dependent replenishment from lymphocyte antigen 6 family member C (Ly6C) hi circulating monocytes via the BMDM intermediate [43, 44].”
BackgroundInfluentialBailey, J. I., Puritz, C. H., Senkow, K. J., Markov, N. S., Diaz, E., Jonasson, E., Yu, Z., Swaminathan, S., Lu, Z., Fenske, S. W., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01975-x · Cited by 85
“3c), were causally implicated in the pathogenesis of pulmonary fibrosis in mouse and in vitro models 4 .”
BackgroundSelf-citationShan, M., Zhang, S., Luo, Z., Deng, S., Ran, L., Zhou, Q., Wan, H., Ye, J., Qian, C., Fan, X., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.012 · Cited by 84
Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease
Ng, B., Dong, J., Viswanathan, S., Widjaja, A. A., Paleja, B. S., Adami, E., Ko, N. S. J., Wang, M., Lim, S., Tan, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001045rr · Cited by 74
Lee, J., Arisi, I., Puxeddu, E., Mramba, L. K., Amicosante, M., Swaisgood, C. M., Pallante, M., Brantly, M. L., Sköld, C. M., & Saltini, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194803 · Cited by 69
Gu, Y., Lawrence, T., Mohamed, R., Liang, Y., & Yahaya, B. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923235 · Cited by 77
“Interestingly, under certain pathological conditions, such as in fibrotic lungs, monocyte-derived macrophages (MDMs) can replenish AMs (36, 61).”
BackgroundAlteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
Bellamri, N., Morzadec, C., Joannes, A., Lecureur, V., Wollin, L., Jouneau, S., & Vernhet, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.061 · Cited by 74
Macrophages as a Source and Recipient of Wnt Signals
Malsin, E., Kim, S., Lam, A., & Gottardi, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01813 · Cited by 67
“Upon injury, Mo-AMs are transcriptionally distinct from TR-AMs.”
BackgroundSelf-citationMorphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
Ackermann, M., Stark, H., Neubert, L., Schubert, S., Borchert, P., Linz, F., Wagner, W. L., Stiller, W., Wielpütz, M. O., Hoefer, A., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00933-2019 · Cited by 68
Xu, Y., Ying, L., Lang, J. K., Hinz, B., & Zhao, R. (2024) · Science Advances · doi:10.1126/sciadv.adj9559 · Cited by 67
“For simplicity, in vitro–generated CD206-positive macrophages are often called M2 phenotypes, recognizing that macrophages exist in a more complex polarization (activation) spectrum in vivo ( 5 , 14 , 21 – 25 ).”
BackgroundMacrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives
Vasse, G. F., Nizamoglu, M., Heijink, I. H., Schlepütz, M., van Rijn, P., Thomas, M. J., Burgess, J. K., & Melgert, B. N. (2021) · The Journal of Pathology · doi:10.1002/path.5632 · Cited by 74
Zhou, B., Liu, H., Xu, F., & Jia, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01557-2 · Cited by 83
“These studies have shown that AMs consist of two distinct populations: tissue-resident AMs and monocyte-derived AMs [14].”
BackgroundWillis, G. R., Fernandez‐Gonzalez, A., Reis, M., Mitsialis, S. A., & Kourembanas, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092534 · Cited by 70
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis
Kania, G., Rudnik, M., & Distler, O. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0212-z · Cited by 71
Hou, J., Ji, J., Chen, X., Cao, H., Tan, Y., Cui, Y., Xiang, Z., & Han, X. (2020) · FEBS Journal · doi:10.1111/febs.15669 · Cited by 67
Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies
Haak, A. J., Ducharme, M. T., Diaz Espinosa, A. M., & Tschumperlin, D. J. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.12.008 · Cited by 65
Zhang, J., Liu, J., Yuan, Y., Huang, F., Ma, R., Luo, B., Xi, Z., Pan, T. S., Liu, B., Zhang, Y., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008334 · Cited by 79
“When viruses are eliminated by neutralization antibody or T cells, the local repopulation of AMs would be dependent on BM-derived monocytes in a short time [12].”
BackgroundFang, S., Zhang, H., Meng, X.-C., Wang, C., He, B., Peng, Y., Xu, Z., Fan, X., Wu, Z.-J., Wu, Z., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2606-x · Cited by 67
Fraser, E., Denney, L., Antanaviciute, A., Blirando, K., Vuppusetty, C., Zheng, Y., Repapi, E., Iotchkova, V., Taylor, S., Ashley, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623430 · Cited by 83
“Levels were higher in IPF patients compared to HC (as % of PBMCs and absolute numbers (per ml of blood; performed in a subset of patients) (Figures 1A, B) [16% (5) v 12% (6); IPF vs HC; p=0.”
Chen, F., El-Naccache, D. W., Ponessa, J. J., Lemenze, A. D., Espinosa, V., Wu, W., Lothstein, K. E., Jin, L., Antao, O. Q., Weinstein, J. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110215 · Cited by 68
Monocyte-derived Alveolar Macrophages: The Dark Side of Lung Repair?
McQuattie‐Pimentel, A. C., Budinger, G. R. S., & Ballinger, M. N. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0328ed · Cited by 72
Self-citationNeuroimmune interactions and osteoarthritis pain: focus on macrophages
Geraghty, T., Winter, D. R., Miller, R. J., Miller, R. E., & Malfait, A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000892 · Cited by 74
“They often maintain their monocyte identity longer and are slow to demonstrate the tissue-resident phenotype.(99,130) Infiltrating macrophages have been shown to be a major driver of fibrosis and tissue damage resulting from inflammation.”
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
Samarelli, A. V., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., Manicardi, L., Moretti, A., Tabbì, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168952 · Cited by 72
“Among these, pro-fibrotic mediators such as transforming growth factor beta-1 (TGF-β1), platelet-derived growth factor (PDGF), tumor necrosis factor (TNF), endothelin-1, connective tissue growth factor (CTGF), osteopontin, and CXC chemokine ligand 12 (CXCL12) [52], which are overexpressed in the AECs of IPF lungs, mod…”
BackgroundInfluentialRolot, M., & Dewals, B. G. (2018) · Journal of Immunology Research · doi:10.1155/2018/2790627 · Cited by 74
“AAM origin could therefore influence their contribution to pathology as observed after bleomycine-induced lung fibrosis [126] or protection against pathogens [117].”
BackgroundRoles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer
Vlahopoulos, S., Adamaki, M., Khoury, N., Zoumpourlis, V. C., & Boldogh, I. R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.004 · Cited by 70
Macrophage Plasticity and Function in the Eye and Heart
Wang, Z., Koenig, A. L., Lavine, K. J., & Apte, R. S. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.07.002 · Cited by 66
“Consistent with other emerging evidence that populations of macrophages are not constrained to their traditional functional roles [15, 25, 27], a recent study in mice showed that both classically inflammatory recruited macrophages and resident macrophages expressed interferon regulatory factor 3 (IRF3) in response to…”
BackgroundChung, E. J., Kwon, S., Reedy, J. L., White, A. O., Song, J. S., Hwang, I., Chung, J., Ylaya, K., Hewitt, S. M., & Citrin, D. E. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.035 · Cited by 66
Recruited atypical Ly6G + macrophages license alveolar regeneration after lung injury
Ruscitti, C., Abinet, J., Maréchal, P., Meunier, M., meeûs, C. D., Vanneste, D., Janssen, P., Dourcy, M., Thiry, M., Bureau, F., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ado1227 · Cited by 67
“…seen as culprits and drivers of disease progression in different contexts, such as in Covid-19, interstitial fibrosis or lung cancer (13, 17, 18, 48), advances in single cell and spatial technologies have enabled new opportunities to investigate the spatiotemporal regulation of Mo-Mac responses…”
BackgroundLercher, A., Cheong, J., Bale, M. J., Jiang, C., Hoffmann, H.-H., Ashbrook, A. W., Lewy, T., Yin, Y. S., Quirk, C., DeGrace, E. J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.018 · Cited by 73
Tighe, R. M., Redente, E. F., Yu, Y.-R. A., Herold, S., Sperling, A. I., Curtis, J. L., Duggan, R., Swaminathan, S., Nakano, H., Zacharias, W. J., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0191st · Cited by 72
Self-citationHuang, K. Y., Mishra, K., Park, H., Yi, X., Ouyang, J. F., Petretto, E. G., & Behmoaras, J. V. (2023) · eLife · doi:10.7554/elife.85530 · Cited by 74
Ferrer, I. R., West, H. C., Henderson, S., Ushakov, D. S., Santos e Sousa, P., Strid, J., Chakraverty, R., Yates, A. J., & Bennett, C. L. (2019) · Science Immunology · doi:10.1126/sciimmunol.aax8704 · Cited by 61
A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice
Ghebremedhin, A., Salam, A. B., Adu-Addai, B., Noonan, S., Stratton, R. J., Ahmed, M. S. U., Khantwal, C. M., Martin, G. R., Lin, H., Andrews, C., et al. (2023) · Cells · doi:10.3390/cells12091254 · Cited by 68
“, demonstrated that in BLM mouse models of lung fibrosis, the deletion of monocyte-derived macrophages after their recruitment to the lung markedly attenuated the severity of fibrosis, whereas the deletion of tissue-resident alveolar macrophages did not affect fibrosis severity [8].”
BackgroundMonocyte differentiation within tissues: a renewed outlook
Rigamonti, A., Villar, J., & Segura, É. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.10.005 · Cited by 68
TNF-α and IL-10 Control CXCL13 Expression in Human Macrophages
Bellamri, N., Viel, R., Morzadec, C., Lecureur, V., Joannes, A., Latour, B. R. D., Llamas‐Gutierrez, F., Wollin, L., Jouneau, S., & Vernhet, L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900790 · Cited by 63
Mariano, L. L., Rousseau, M., Varet, H., Legendre, R., Gentek, R., Coronilla, J. S., Bajénoff, M., Perdiguero, E. G., & Ingersoll, M. A. (2020) · Science Advances · doi:10.1126/sciadv.abc5739 · Cited by 63
Phenotypic alteration of macrophages during osteoarthritis: a systematic review
Zhu, X., Lee, C., Xu, H., Wang, Y.-F., Yung, P. S., Jiang, Y., & Lee, O. K. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02457-3 · Cited by 64
“Tissue-resident macrophages expressed relatively higher levels of “M2-like” markers in comparison with mature monocyte-derived macrophages [83, 84].”
BackgroundAgeing mechanisms that contribute to tissue remodeling in lung disease
Schuliga, M. J., Read, J. M., & Knight, D. A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101405 · Cited by 64
VEGF-C/VEGFR-3 signalling in macrophages ameliorates acute lung injury
Yamashita, M., Niisato, M., Kawasaki, Y., Karaman, S., Robciuc, M. R., Shibata, Y., Ishida, Y., Nishio, R., Masuda, T., Sugai, T., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00880-2021 · Cited by 63
The spatial and temporal activation of macrophages during fibrosis
Behmoaras, J. V., Mulder, K., Ginhoux, F., & Petretto, E. G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01186-x · Cited by 84
“Monocyte-derived alveolar macrophages stay in the lung for one year after the resolution of fibrosis, adopting a phenotype that resembles tissue-resident macrophages 88 .”
Tsitoura, E., Vasarmidi, E., Bibaki, E., Trachalaki, A., Koutoulaki, C., Papastratigakis, G., Papadogiorgaki, S., Chalepakis, G., Tzanakis, N., & Antoniou, K. M. (2019) · Respiratory Research · doi:10.1186/s12931-019-1196-6 · Cited by 64
“Recent studies propose that a diverse population of macrophages exists in IPF lungs with both pro-inflammatory and pro-fibrotic gene expression [18, 19, 49, 50].”
BackgroundMethodThe Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Effendi, W. I., & Nagano, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010171 · Cited by 59
Sang, X., Wang, Y., Xue, Z., Qi, D., Fan, G., Tian, F., Zhu, Y., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613907 · Cited by 59
“In addition, macrophages also can migrate to inflammation sites (9).”
BackgroundTargeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 64
Mia, M. M., Ghani, S. A. B. A., Cibi, D. M., Bogireddi, H., Nilanthi, U., Selvan, A., Shiu, W., & Singh, M. K. (2025) · European Respiratory Journal · doi:10.1183/13993003.01544-2023 · Cited by 73
“Studies have shown that aberrant activation, infiltration and polarisation of pro-fibrotic Mo-AMs, and their interaction with fibroblasts, are major factors driving the development of pulmonary fibrosis [7, 10, 43, 49, 53, 63].”
InfluentialModeling radiation-induced lung injury: lessons learned from whole thorax irradiation
Beach, T. A., Groves, A. M., Williams, J. P., & Finkelstein, J. N. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1532619 · Cited by 69
“2013), bleomycin exposure (Misharin et al. 2017) and silica instillation (Lebrun et al.”
BackgroundImmune determinants of chronic sequelae after respiratory viral infection
Narasimhan, H., Wu, Y., Goplen, N. P., & Sun, J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm7996 · Cited by 67
Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis
Song, L., Li, K., Chen, H., & Xie, L. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0426tr · Cited by 71
“Macrophages have a considerable impact on fi brosis by interacting with epithelial cells and Fbs. Injured epithelial cells release signals that attract and activate macrophages at the injury site, leading to a proin fl ammatory environment (102).”
BackgroundTargeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling
Gu, L., Surolia, R., Larson‐Casey, J. L., He, C., Davis, D., Kang, J., Antony, V. B., & Carter, A. B. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00840-w · Cited by 60
Interrelation of adipose tissue macrophages and fibrosis in obesity
Dahdah, N., Tercero‐Alcázar, C., Malagón, M. M., García-Rovés, P. M., & Guzmán‐Ruiz, R. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116324 · Cited by 66
“However, several investigations on different tissues of mouse models showed that a depletion of monocyte-derived macrophages lead to reduced fibrosis [124 – 128].”
Oral submucous fibrosis: pathogenesis and therapeutic approaches
Tang, J., Liu, J., Zhou, Z., Cui, X., Tu, H., Jia, J., Chen, B., Dai, X., & Liu, O. (2025) · International Journal of Oral Science · doi:10.1038/s41368-024-00344-6 · Cited by 65
Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis
Vukmirovic, M., & Kaminski, N. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00087 · Cited by 64
“Thus, selective targeting of alveolar macrophage differentiation within the lung may decrease fibrosis and avoid global monocyte or tissue-resident alveolar macrophage depletion (125).”
BackgroundChen, Y., Wang, T., Liang, F., Han, J., Lou, Z., Yu, Y., Li, J., Zhan, T., Gu, Y., Dong, L., et al. (2024) · Theranostics · doi:10.7150/thno.94482 · Cited by 60
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool [61].”
BackgroundCheca, J., & Aran, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239317 · Cited by 61
Alveolar Macrophages: Adaptation to Their Anatomic Niche during and after Inflammation
Martin, F. P., Jacqueline, C., Poschmann, J., & Roquilly, A. (2021) · Cells · doi:10.3390/cells10102720 · Cited by 62
“Interestingly, the expression of profibrotic genes by InfAM was induced locally after the recruitment into the lung tissue, and then decreased over time [58].”
BackgroundCellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics
Froom, Z. S. C. S., Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110203 · Cited by 69
DNA methylation regulates the neonatal CD4+ T-cell response to pneumonia in mice
McGrath‐Morrow, S. A., Ndeh, R., Helmin, K. A., Chen, S.-Y., Anekalla, K. R., Abdala‐Valencia, H., D’Alessio, F. R., Collaco, J. M., & Singer, B. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003589 · Cited by 57
Self-citationActivation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease
Cornwell, W. D., Kim, V., Fan, X., Vega, M. E., Ramsey, F. V., Criner, G. J., & Rogers, T. J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0664-y · Cited by 57
“However, more recent evidence shows that the extravasation of monocytes into the lungs initiates differentiation of these cells into new macrophages, and these differentiated cells can persist in the lung tissue for the life span of the animal [10].”
BackgroundXu, Q., Mei, S., Nie, F., Zhang, Z., Feng, J., Zhang, J., Qian, X., Gao, Y., He, Z., & Xing, S. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00701-7 · Cited by 55
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“Using flow cytometry analysis of murine and human lungs for unambiguous identification of pulmonary myeloid cell populations and targeted murine transgenics, an essential role for monocytederived AM (Mo-AMs), rather than tissue resident AMs, was necessary for mediating bleomycin-induced murine lung fibrosis and these…”
BackgroundInfluentialDunlap, M. D., Howard, N. C., Das, S., Scott, N. R., Ahmed, M., Prince, O. A., Rangel‐Moreno, J., Rosa, B. A., Martin, J. C., Kaushal, D., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0071-y · Cited by 66
“We confirmed that both populations were in fact bonafide AMs by examining the common AM gene signature 22,23 between groups (i.e. Siglecf, Pparg, Tgfbr2, Csf2r, Mertk, Itgax, Lyz2, and Fcgr1).”
Krljanac, B., Schubart, C., Naumann, R., Wirtz, S. J., Culemann, S., Krönke, G., & Voehringer, D. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau3814 · Cited by 58
Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases
Zhu, J., Wang, S., Yang, D., Xu, W., & Qian, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01921-3 · Cited by 70
“Combined with both positive and negative regulatory effects, macrophages are considered as important mediator in PF [52, 53].”
BackgroundVenosa, A., Katzen, J. B., Tomer, Y., Kopp, M. C., Jamil, S., Russo, S. J., Mulugeta, S., & Beers, M. F. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900039 · Cited by 53
CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages
Evren, E., Ringqvist, E. E., Doisne, J., Thaller, A., Sleiers, N., Flavell, R. A., Santo, J. P. D., & Willinger, T. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210987 · Cited by 62
The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
Planté-Bordeneuve, T., Pilette, C., & Froidure, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631235 · Cited by 67
Gorki, A.-D., Symmank, D., Zahalka, S., Lakovits, K., Hladik, A., Langer, B., Maurer, B., Sexl, V., Kain, R., & Knapp, S. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0190oc · Cited by 56
Dumigan, A., Cappa, O., Morris, B., Sá‐Pessoa, J., Calderón-González, R., Mills, G., Lancaster, R., Simpson, D. A. C., Kissenpfennig, A., & Bengoechea, J. A. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216888 · Cited by 58
“…that in our analysis we cannot differentiate between alveolar macrophages and monocyte-derived alveolar macrophages although the latter are recruited to the lungs within 3 – 7 days (Misharin et al , 2017; Aegerter et al , 2020; Arafa et al , 2022) and our experiments were done 24 h post infection.”
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Yanagihara, T., Sato, S., Upagupta, C., & Kolb, M. R. J. (2019) · European Respiratory Review · doi:10.1183/16000617.0029-2019 · Cited by 59
Cargnoni, A., Romele, P., Signoroni, P. B., Farigu, S., Magatti, M., Vertua, E., Toschi, I., Cesari, V., Silini, A. R., Stefani, F. R., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0068 · Cited by 53
Theobald, H., Bejarano, D. A., Katzmarski, N., Haub, J., Schulte-Schrepping, J., Yu, J., Bassler, K. E., Ament, A. L., Osei-Sarpong, C., Piattini, F., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01830-z · Cited by 56
Nature and nurture of tissue-specific macrophage phenotypes
Hoeksema, M. A., & Glass, C. K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.005 · Cited by 58
Epigenomic and enhancer dysregulation in uterine leiomyomas
Mlodawska, O. W., Saini, P., Parker, J. B., Wei, J., Bulun, S. E., Simon, M. A., & Chakravarti, D. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac008 · Cited by 60
Walter, J. M., Ren, Z., Yacoub, T. J., Reyfman, P. A., Shah, R. D., Abdala‐Valencia, H., Nam, K.-W., Morgan, V. K., Anekalla, K. R., Joshi, N., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0650oc · Cited by 52
“Lavage Fluid Processing and Cell Sorting All lavage samples were processed for flowcytometry sorting within 12 hours of collection using a modification of a previously described procedure, as detailed in the online supplement (21, 22).”
BackgroundMethodResultSelf-citationDooming Phagocyte Responses: Inflammatory Effects of Endogenous Oxidized Phospholipids
Gioia, M. D., & Zanoni, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626842 · Cited by 53
King, E. M., Zhao, Y., Moore, C. M., Steinhart, B., Anderson, K. C., Vestal, B. E., Moore, P. K., McManus, S. A., Evans, C. M., Mould, K. J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182700 · Cited by 59
“Importantly, strategies that block monocyte recruitment or lead to depletion of recruited lung macrophages attenuate fibrosis in fibrotic lung injury models (18, 19, 21, 22).”
Moroncini, G., Paolini, C., Orlando, F., Capelli, C., Grieco, A., Tonnini, C., Agarbati, S., Mondini, E., Saccomanno, S., Goteri, G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196048 · Cited by 52
“It must be noted that our study did not differentiate the total lung macrophage population from recruited circulating monocytes, which have been shown to be a major player in lung fibrosis[43] and therefore could also be the target of hUC-MSC.”
Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury
Bałuk, P., Naikawadi, R. P., Kim, S., Rodriguez, F., Choi, D., Hong, Y., Wolters, P. J., & McDonald, D. M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.018 · Cited by 55
Senescence in Pulmonary Fibrosis: Between Aging and Exposure
Venosa, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606462 · Cited by 54
“These immature myeloid cells have been shown to mature into macrophages, replenish the alveolar compartment, and persist in the tissue for extended periods after bleomycin induced injury, where they elicit a fibrotic phenotype (100, 179, 237).”
BackgroundLv, J., Gao, H., Ma, J., Liu, J., Tian, Y., Yang, C., Li, M., Zhao, Y., Li, Z., Zhang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230266 · Cited by 48
“Some studies indicate that monocytes are the source of AMs in inflammatory conditions (53, 54), and termed those AMs as mo-AMs (monocytes-derived AMs) to distinguish them from TRAMs (tissue-resident AMs).”
BackgroundPathogenesis of systemic sclerosis: an integrative review of recent advances
Son, H.-Y., & Moon, S. (2024) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2024.0129 · Cited by 61
“CD14 + monocytes/macrophages, prevalent in SSc skin, migrate and differentiate into alveolar macrophages, exhibiting impaired efferocytosis capacities and resulting in sustained inflammation [62].”
Dong, Y., Poon, G. F. T., Arif, A. A., Lee‐Sayer, S. S. M., Dosanjh, M., & Johnson, P. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.83 · Cited by 53
“Recent work shows monocyte-derived cells present in the lung 10 months after bleomycin-induced injury that express equal levels of Siglec F and have a very similar transcriptional signature to tissueresident AM^.(26) This report shows that the CD44 expressed on both fetal and BM-derived AM^ is important for their surv…”
BackgroundLRP1: A chameleon receptor of lung inflammation and repair
Wujak, L. A., Schnieder, J., Schaefer, L., & Wygrecka, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.12.007 · Cited by 50
Lung Secretoglobin Scgb1a1 Influences Alveolar Macrophage-Mediated Inflammation and Immunity
Xu, M., Yang, W., Wang, X., & Nayak, D. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584310 · Cited by 51
“Developmental origin and physiologic significance of the CD11chi and Siglec-Flow cells in Scgb1a1−/− is currently unknown; however, some unrelated studies have suggested a monocytic precursor for the Siglec-Flow pulmonary macrophages (52, 53).”
BackgroundResultRole of donor macrophages after heart and lung transplantation
Kopecky, B. J., Frye, C. C., Terada, Y., Balsara, K. R., Kreisel, D., & Lavine, K. J. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15751 · Cited by 51
Samaniego, R., Domínguez‐Soto, Á., Ratnam, M., Matsuyama, T., Sánchez‐Mateos, P., Corbí, A. L., & Puig‐Kröger, A. (2020) · Cells · doi:10.3390/cells9061445 · Cited by 56
Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
Zhang, K., Xu, L., & Cong, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739810 · Cited by 54
Moore, P. K., Anderson, K. C., McManus, S. A., Tu, T.-H. C., King, E. M., Mould, K. J., Redente, E. F., Henson, P. M., Janssen, W. J., & McCubbrey, A. L. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00223.2022 · Cited by 54
Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
Nayak, D. K., Mendez, O. A., Bowen, S. K., & Mohanakumar, T. (2018) · Journal of Visualized Experiments · doi:10.3791/57287 · Cited by 63
Biomimetic collagen biomaterial induces in situ lung regeneration by forming functional alveolar
Wang, L., Zhao, Y., Yang, F., Feng, M., Zhao, Y., Chen, X., Mi, J., Yao, Y., Guan, D., Xiao, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119825 · Cited by 50
Cheresh, P., Kim, S.-J., Jablonski, R. P., Watanabe, S., Lu, Z., Chi, M., Helmin, K. A., Gius, D. R., Budinger, G. R. S., & Kamp, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136856 · Cited by 53
Self-citationPham, T. X., Lee, J., Guan, J., Caporarello, N., Meridew, J. A., Jones, D. L., Tan, Q., Huang, S. K., Tschumperlin, D. J., & Ligresti, G. (2022) · JCI Insight · doi:10.1172/jci.insight.153672 · Cited by 48
“In this regard, recent studies showed that the recruitment of monocyte-derived alveolar macrophages in response to lung injury plays a pathogenic role in lung fibrosis and that their ablation attenuated disease progression (59, 60).”
ResultCellular uptake of collagens and implications for immune cell regulation in disease
Jürgensen, H. J., van Putten, S., Nørregaard, K. S., Bugge, T. H., Engelholm, L. H., Behrendt, N., & Madsen, D. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03481-3 · Cited by 50
Development of an Optimized Culture System for Generating Mouse Alveolar Macrophage–like Cells
Luo, M., Lai, W., He, Z., & Wu, L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100185 · Cited by 45
Liu, Z., Liao, F., Zhu, J., Zhou, D., Heo, G. S., Leuhmann, H. P., Scozzi, D., Parks, A., Hachem, R. R., Byers, D. E., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159229 · Cited by 47
“However, in response to pulmonary injury, TR-AM levels fall, which is coincident with the generation of monocyte-derived AMs (Mo-AMs) (23).”
InfluentialLi, C., Qian, W., Wei, X., Narasimhan, H., Wu, Y., Arish, M., Cheon, I. S., Tang, J., Santos, G. D. A., Li, Y., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn0136 · Cited by 59
Alveolar injury and regeneration following deletion of ABCA3
Rindler, T. N., Stockman, C. A., Filuta, A. L., Brown, K. M., Snowball, J. M., Zhou, W., Veldhuizen, R. A. W., Zink, E., Dautel, S. E., Clair, G., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.97381 · Cited by 49
“While M2 monocytic–derived macrophages have been implicated in profibrotic processes (43), we did not observe fibrotic remodeling in the present mouse model.”
BackgroundComputational Approach to Identifying Universal Macrophage Biomarkers
Dang, D., Taheri, S., Das, S., Ghosh, P., Prince, L. S., & Sahoo, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00275 · Cited by 48
The Role of TRPV4 in Regulating Innate Immune Cell Function in Lung Inflammation
Scheraga, R. G., Southern, B. D., Grove, L. M., & Olman, M. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01211 · Cited by 52
“In contrast, recruited lung macrophages populate the lung only after injury and are derived from circulating monocytes that originated from the bone marrow (14, 15, 18).”
BackgroundAyaub, E., Poli, S., Ng, J., Adams, T., Schupp, J., Quesada-Arias, L., Poli, F., Cosme, C., Robertson, M., Martinez-Manzano, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.04.425268 · Cited by 45
“that monocyte-derived alveolar macrophages contribute to driving fibrotic responses(46).”
BackgroundMethodInfluential
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.